Biotechnology company, Veracyte, Inc. (VCYT) Monday announced that it expects higher revenue for fourth quarter and fiscal year 2023 mainly due to growth of its Afirma and Decipher businesses.
C2i Genomics and OncoDNA Begin Molecular Residual Disease Testing Across Europe
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.
C2i Genomics and Gustave Roussy Collaborate to Demonstrate Utility of ctDNA-guided Immunotherapy in Early-Stage Solid Tumors
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.
C2i Genomics and Ichilov Join Forces to Bring Cancer Detection and Monitoring Platform to Israel
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.